Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Mesenchymal Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03006848
What this trial is testing

A Phase II Trial of Avelumab in Patients With Recurrent or Progressive Osteosarcoma

Who this might be right for
Osteosarcoma
St. Jude Children's Research Hospital 19
Testing effectiveness (Phase 2)UnknownNCT05518526
What this trial is testing

Phase 1b/2 Study of Liposomal Annamycin (L-Annamycin) in Subjects With Previously Treated Soft-Tissue Sarcomas (STS) With Pulmonary Metastases

Who this might be right for
Soft Tissue SarcomaPulmonary Metastasis
Maria Sklodowska-Curie National Research Institute of Oncology 64
Not applicableStudy completedNCT02192333
What this trial is testing

Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors

Who this might be right for
Breast CarcinomaCancer SurvivorDepression+10 more
Fred Hutchinson Cancer Center 390
Testing effectiveness (Phase 2)Active Not RecruitingNCT04968106
What this trial is testing

Neoadjuvant Chemotherapy and Retifanlimab in Patients With Selected Sarcomas (TORNADO)

Who this might be right for
Resectable Sarcoma
Institut Bergonié 66
Large-scale testing (Phase 3)Study completedNCT00006348
What this trial is testing

Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+7 more
Alliance for Clinical Trials in Oncology 100
Early research (Phase 1)Ended earlyNCT06336148
What this trial is testing

A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Actym Therapeutics, Inc. 10
Not applicableActive Not RecruitingNCT06850506
What this trial is testing

Exploring the Expression Level of Cadherin 6 Protein (CDH6) in Primary Malignant Bone Tumor Specimens and Its Clinical Application in Prognosis Assessment

Who this might be right for
SarcomaSarcoma, BoneEwing Sarcoma+1 more
Peking University People's Hospital 70
Testing effectiveness (Phase 2)UnknownNCT03946943
What this trial is testing

Study of Anlotinib Hydrochloride and Toripalimab in Subjects With Unresectable or Metastatic Undifferentiated Pleomorphic Sarcoma

Who this might be right for
Soft Tissue SarcomasUndifferentiated Pleomorphic Sarcoma
Di Wu 25
Early research (Phase 1)Ended earlyNCT00087009
What this trial is testing

Beta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia, or Lymphoproliferative Disorder Related to Donor Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaLymphoproliferative Disorder
Memorial Sloan Kettering Cancer Center 3
Not applicableStudy completedNCT00592293
What this trial is testing

Proton Radiation for the Treatment of Pediatric Bone and Non-Rhabdomyosarcoma Soft Tissue Sarcomas

Who this might be right for
Non-rhabdomyosarcoma Soft Tissue SarcomaBone Sarcoma
Massachusetts General Hospital 70
Testing effectiveness (Phase 2)Study completedNCT02875548
What this trial is testing

Assess Long-term Safety of Tazemetostat in Adult Participants of All Ages With Any Disease Treated With Tazemetostat in a Previous Clinical Study

Who this might be right for
Diffuse Large B-cell Lymphoma (DLBCL)Follicular Lymphoma (FL)Synovial Sarcoma+5 more
Epizyme, Inc. 58
Testing effectiveness (Phase 2)Looking for participantsNCT06827717
What this trial is testing

Phase II Study of Irinotecan Liposome (II) Combined With Temozolomide and Fluzoparib in Recurrent or Metastatic Ewing Sarcoma

Who this might be right for
Ewing Sarcoma
Sun Yat-sen University 29
Early research (Phase 1)Study completedNCT00002936
What this trial is testing

Altretamine and Etoposide in Treating Patients With HIV-Related Cancer

Who this might be right for
LymphomaSarcoma
Roswell Park Cancer Institute
Large-scale testing (Phase 3)Study completedNCT01376349
What this trial is testing

Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms

Who this might be right for
Breast CancerGynecologic Cancer
Alliance for Clinical Trials in Oncology 464
Large-scale testing (Phase 3)Study completedNCT00131898
What this trial is testing

A Prospective Randomized Trial of Pre-Operative IMRT+Surgery Versus Surgery Alone For Primary Retroperitoneal Sarcoma

Who this might be right for
Sarcoma
Memorial Sloan Kettering Cancer Center 150
Not applicableStudy completedNCT01841047
What this trial is testing

Assessment of Helical Tomotherapy Radiotherapy (54 Gy) Followed by Surgery in Retro-peritoneal Liposarcoma

Who this might be right for
Liposarcoma
Institut Bergonié 48
Not applicableNot Yet RecruitingNCT06500715
What this trial is testing

Acupuncture as add-on to G-CSF for Febrile Neutropenia-related Hospitalization in Doxorubicin-treated Patients With Sarcoma

Who this might be right for
Febrile NeutropeniaSarcomaDoxorubicin Adverse Reaction+1 more
Shaare Zedek Medical Center 60
Testing effectiveness (Phase 2)Study completedNCT00003408
What this trial is testing

Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Cancer Treatment Centers of America 40
Testing effectiveness (Phase 2)Study completedNCT03997968
What this trial is testing

CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors

Who this might be right for
MalignancyNon-hodgkin LymphomaMultiple Myeloma+12 more
Cyteir Therapeutics, Inc. 169
Not applicableEnded earlyNCT00255684
What this trial is testing

Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
University of Rochester 16
Next Page